相似文献
1
Is It Possible to Develop a "Universal" Influenza Virus Vaccine? Potential for a Universal Influenza Vaccine.
Cold Spring Harb Perspect Biol. 2018 Jul 2;10(7):a029496. doi: 10.1101/cshperspect.a029496.
2
Conformational Stability of the Hemagglutinin of H5N1 Influenza A Viruses Influences Susceptibility to Broadly Neutralizing Stem Antibodies.
J Virol. 2018 May 29;92(12). doi: 10.1128/JVI.00247-18. Print 2018 Jun 15.
3
Is It Possible to Develop a "Universal" Influenza Virus Vaccine? Immunogenetic Considerations Underlying B-Cell Biology in the Development of a Pan-Subtype Influenza A Vaccine Targeting the Hemagglutinin Stem.
Cold Spring Harb Perspect Biol. 2018 Jul 2;10(7):a029413. doi: 10.1101/cshperspect.a029413.
4
Broadly neutralizing anti-influenza virus antibodies: enhancement of neutralizing potency in polyclonal mixtures and IgA backbones.
J Virol. 2015 Apr;89(7):3610-8. doi: 10.1128/JVI.03099-14. Epub 2015 Jan 14.
5
Antibodies to antigenic site A of influenza H7 hemagglutinin provide protection against H7N9 challenge.
PLoS One. 2015 Jan 28;10(1):e0117108. doi: 10.1371/journal.pone.0117108. eCollection 2015.
6
Towards a universal influenza vaccine: different approaches for one goal.
Virol J. 2018 Jan 19;15(1):17. doi: 10.1186/s12985-017-0918-y.
7
Prospects of HA-based universal influenza vaccine.
Biomed Res Int. 2015;2015:414637. doi: 10.1155/2015/414637. Epub 2015 Feb 15.
8
Novel hemagglutinin nanoparticle influenza vaccine with Matrix-M™ adjuvant induces hemagglutination inhibition, neutralizing, and protective responses in ferrets against homologous and drifted A(H3N2) subtypes.
Vaccine. 2017 Sep 25;35(40):5366-5372. doi: 10.1016/j.vaccine.2017.08.021. Epub 2017 Aug 22.
9
Implications of broadly neutralizing antibodies in the development of a universal influenza vaccine.
Curr Opin Virol. 2016 Apr;17:110-115. doi: 10.1016/j.coviro.2016.03.002. Epub 2016 Mar 28.
10
Elicitation of broadly neutralizing influenza antibodies in animals with previous influenza exposure.
Sci Transl Med. 2012 Aug 15;4(147):147ra114. doi: 10.1126/scitranslmed.3004273.
引用本文的文献
1
Dual neutralization of influenza virus hemagglutinin and neuraminidase by a bispecific antibody leads to improved antiviral activity.
Mol Ther. 2024 Oct 2;32(10):3712-3728. doi: 10.1016/j.ymthe.2024.07.023. Epub 2024 Jul 31.
2
Quantitatively Visualizing Bipartite Datasets.
Phys Rev X. 2023 Apr-Jun;13(2). doi: 10.1103/physrevx.13.021002. Epub 2023 Apr 4.
3
Differential recognition of influenza A virus H1N1 neuraminidase by DNA vaccine-induced antibodies in pigs and ferrets.
Front Immunol. 2023 May 29;14:1200718. doi: 10.3389/fimmu.2023.1200718. eCollection 2023.
4
An influenza hemagglutinin stem nanoparticle vaccine induces cross-group 1 neutralizing antibodies in healthy adults.
Sci Transl Med. 2023 Apr 19;15(692):eade4790. doi: 10.1126/scitranslmed.ade4790.
5
Magnitude and breadth of antibody cross-reactivity induced by recombinant influenza hemagglutinin trimer vaccine is enhanced by combination adjuvants.
Sci Rep. 2022 Jun 2;12(1):9198. doi: 10.1038/s41598-022-12727-y.
6
A Novel Immunobiotics Ameliorates Influenza Virus Infection in Mice.
Front Immunol. 2022 Jan 26;12:828887. doi: 10.3389/fimmu.2021.828887. eCollection 2021.
7
Hide and seek: interplay between influenza viruses and B cells.
Int Immunol. 2020 Sep 8;32(9):605-611. doi: 10.1093/intimm/dxaa028.
8
Next-Generation Influenza Vaccines.
Cold Spring Harb Perspect Med. 2021 Aug 2;11(8):a038448. doi: 10.1101/cshperspect.a038448.
9
Hemagglutinin head-specific responses dominate over stem-specific responses following prime boost with mismatched vaccines.
JCI Insight. 2019 Nov 14;4(22):129035. doi: 10.1172/jci.insight.129035.
10
The Quest for a Truly Universal Influenza Vaccine.
Front Cell Infect Microbiol. 2019 Oct 10;9:344. doi: 10.3389/fcimb.2019.00344. eCollection 2019.
本文引用的文献
1
Broadly Neutralizing Hemagglutinin Stalk-Specific Antibodies Induce Potent Phagocytosis of Immune Complexes by Neutrophils in an Fc-Dependent Manner.
mBio. 2016 Oct 4;7(5):e01624-16. doi: 10.1128/mBio.01624-16.
2
Epitope specificity plays a critical role in regulating antibody-dependent cell-mediated cytotoxicity against influenza A virus.
Proc Natl Acad Sci U S A. 2016 Oct 18;113(42):11931-11936. doi: 10.1073/pnas.1609316113. Epub 2016 Oct 3.
3
A broadly neutralizing anti-influenza antibody reveals ongoing capacity of haemagglutinin-specific memory B cells to evolve.
Nat Commun. 2016 Sep 13;7:12780. doi: 10.1038/ncomms12780.
4
Structure and Function Analysis of an Antibody Recognizing All Influenza A Subtypes.
Cell. 2016 Jul 28;166(3):596-608. doi: 10.1016/j.cell.2016.05.073. Epub 2016 Jul 21.
5
Association between Hemagglutinin Stem-Reactive Antibodies and Influenza A/H1N1 Virus Infection during the 2009 Pandemic.
J Virol. 2016 Jun 24;90(14):6549-6556. doi: 10.1128/JVI.00093-16. Print 2016 Jul 15.
6
Cryo-electron Microscopy Structures of Chimeric Hemagglutinin Displayed on a Universal Influenza Vaccine Candidate.
mBio. 2016 Mar 22;7(2):e00257. doi: 10.1128/mBio.00257-16.
7
IGHV1-69 polymorphism modulates anti-influenza antibody repertoires, correlates with IGHV utilization shifts and varies by ethnicity.
Sci Rep. 2016 Feb 16;6:20842. doi: 10.1038/srep20842.
8
Hemagglutinin-stem nanoparticles generate heterosubtypic influenza protection.
Nat Med. 2015 Sep;21(9):1065-70. doi: 10.1038/nm.3927. Epub 2015 Aug 24.
9
Influenza-specific antibody-dependent cellular cytotoxicity: toward a universal influenza vaccine.
J Immunol. 2014 Jul 15;193(2):469-75. doi: 10.4049/jimmunol.1400432.
10
Glycan masking of hemagglutinin for adenovirus vector and recombinant protein immunizations elicits broadly neutralizing antibodies against H5N1 avian influenza viruses.
PLoS One. 2014 Mar 26;9(3):e92822. doi: 10.1371/journal.pone.0092822. eCollection 2014.
Zotero 插件